Terms ending in 2035
Every in-force patent on Merck Sharp and Dohme LLC's record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,718,808 | Inhibitors of the Renal Outer Medullary Potassium Channel In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 9,708,336 | Metallo-Beta-Lactamase Inhibitors In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 10,994,008 | Modulation of Tumor Immunity In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 10,117,836 | Tablet Formulation for CGRP Active Compounds In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 11,925,709 | Tablet Formulation for CGRP Active Compounds In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 12,168,004 | Treatment of Migraine In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 12,220,408 | Treatment of Migraine In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 12,310,953 | Pharmaceutical Formulations for the Treatment of Migraine In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 10,059,667 | Antidiabetic Compounds In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 10,570,202 | Combination of a PD-1 Antagonist and a Vegfr Inhibitor for Treating Cancer In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| 153 more term ends in 2035 · Pro | |||||
10 of 163 patents shown. Soonest term end first, then patent number.
Pro members see all 163.
162 of these are in force and held by Merck Sharp and Dohme LLC.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.